Intellectual demand and formal education as: cognitive protection factors in Alzheimer's disease

Intellectual demand and formal education as: cognitive protection factors in Alzheimer's disease

Abstract To investigate the possible association between educational level and previous professional occupation, and objective cognitive and functional evaluation in a sample of elderly patients with Alzheimer's disease. Methods: Through retrospective analysis of medical files, 174 patients wit...

Full description

Bibliographic Details
Main Authors:	José Roberto Wajman, Paulo Henrique Ferreira F. Bertolucci
Format:	Article
Language:	English
Published:	Associação Neurologia Cognitiva e do Comportamento
Series:	Dementia & Neuropsychologia
Subjects:	educational level neuropsychological assessment Alzheimer's disease
Online Access:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1980-57642010000400320&lng=en&tlng=en

Similar Items

Cognition comes of age: comments on the new FDA draft guidance for early Alzheimer’s disease
by: John E. Harrison
Published: (2018-06-01)

Neuropsychological Evaluation and Quantitative EEG in Patients with Frontotemporal Dementia, Alzheimer’s Disease, and Mild Cognitive Impairment
by: Letteria Tomasello, et al.
Published: (2023-06-01)

A survey of smartphone and interactive video technology use by participants in Alzheimer's disease research: Implications for remote cognitive assessment
by: Diane M. Jacobs, et al.
Published: (2021-01-01)

A Comparison of Machine Learning Algorithms for Predicting Alzheimer’s Disease Using Neuropsychological Data
by: Zakaria Mokadem, et al.
Published: (2024-12-01)

Practice effects in a longitudinal, multi-center Alzheimer’s disease prevention clinical trial
by: Abner Erin L, et al.
Published: (2012-11-01)

Neuropsychological differences between frontotemporal lobar degeneration and Alzheimer's disease
by: Claudia Sellitto Porto, et al.

Validity study of Animal-City Alternating Form Fluency Test in the identification of mild cognitive impairment and Alzheimer's disease
by: Yun-bo SHI, et al.
Published: (2015-07-01)

Process approach as a cognitive biomarker related to gray matter volume in mild cognitive impairment and Alzheimer’s disease
by: Wenhao Zhu, et al.
Published: (2024-06-01)

BDNF and cognitive function in Alzheimer’s disease
by: A. Sidenkova
Published: (2022-06-01)

Brief cognitive battery in the diagnosis of mild Alzheimer's disease in subjects with medium and high levels of education
by: Ricardo Nitrini, et al.

Assessment for Alzheimer’s Disease Advancement Using Classification Models with Rules
by: Fadi Thabtah, et al.
Published: (2023-11-01)

A reanalysis of Cognitive-functional performance in older adults: investigating the interaction between normal aging, mild cognitive impairment, mild Alzheimer's disease dementia and depression
by: Jonas Jardim de Paula, et al.
Published: (2016-01-01)

Detection of cerebrospinal fluid biomarkers changes of Alzheimer’s disease using a cognitive stress test in persons with subjective cognitive decline and mild cognitive impairment
by: Maria Valles-Salgado, et al.
Published: (2024-06-01)

FDG-PET-based neural correlates of Addenbrooke’s cognitive examination III scores in Alzheimer’s disease and frontotemporal degeneration
by: María Nieves Cabrera-Martín, et al.
Published: (2023-11-01)

Neuropsychological profiles and neural correlates in typical and atypical variants of Alzheimer disease: A systematic qualitative review
by: C. Fredes-Roa, et al.
Published: (2023-07-01)

Validation of the European Cross-Cultural Neuropsychological Test Battery (CNTB) for the assessment of mild cognitive impairment due to Alzheimer's disease and Parkinson's disease
by: Alfonso Delgado-Álvarez, et al.
Published: (2023-05-01)

Accuracy of the Brazilian version of the Prefrontal Symptoms Inventory (PSI-16) in the neuropsychological assessment of patients diagnosed with Alzheimer's disease
by: Olívia Dayse Leite Ferreira, et al.
Published: (2022-10-01)

Memory markers in the continuum of the Alzheimer’s clinical syndrome
by: Mario A. Parra, et al.
Published: (2022-09-01)

Comparison of the neuropsychological function in adults with Down syndrome with and without Alzheimer disease
by: معصومه طیب لی, et al.
Published: (2016-08-01)

Clinical heterogeneity of neuro-inflammatory PET profiles in early Alzheimer’s disease
by: Dominique Gouilly, et al.
Published: (2023-07-01)

Can neurocognitive assessment be a lower-cost substitute for biomarkers in predicting progression from mild cognitive impairment (MCI) to Alzheimer’s disease (AD)? A narrative review
by: Lea Daou, et al.
Published: (2023-12-01)

Different meanings of a three-point decline in MMSE score in Alzheimer's disease and depressive disorder
by: Karolina Sejunaite, et al.
Published: (2024-09-01)

The clinical and neuropsychological profiles of Alzheimer’s disease with white matter hyperintensity in North China
by: Yuan Chen, et al.
Published: (2024-10-01)

Dual Semi-Supervised Learning for Classification of Alzheimer’s Disease and Mild Cognitive Impairment Based on Neuropsychological Data
by: Yan Wang, et al.
Published: (2023-02-01)

Psychometric properties of Cognitive Instruments in Vascular Dementia and Alzheimer’s disease: a neuropsychological study
by: Juliana Francisca Cecato, et al.
Published: (2020-03-01)

Cognitive profiles of patients with mild cognitive impairment due to Alzheimer's versus Parkinson's disease defined using a base rate approach: Implications for neuropsychological assessments
by: Anja Ophey, et al.
Published: (2021-01-01)

NeuropsychBrainAge: A biomarker for conversion from mild cognitive impairment to Alzheimer's disease
by: Jorge Garcia Condado, et al.
Published: (2023-10-01)

Clinical validity of the Italian adaptation of the Uniform Data Set Neuropsychological Test Battery (I-UDSNB) in Mild Cognitive Impairment and Alzheimer’s Disease
by: Francesca Conca, et al.
Published: (2024-05-01)

Intraindividual Variability across Neuropsychological Tests: Dispersion and Disengaged Lifestyle Increase Risk for Alzheimer’s Disease
by: Drew W. R. Halliday, et al.
Published: (2018-03-01)

Neuropsychological Performance Is Correlated With Tau Protein Deposition and Glucose Metabolism in Patients With Alzheimer’s Disease
by: Zhen Qiao, et al.
Published: (2022-05-01)

Validation of a novel computerized cognitive function test for the rapid detection of mild cognitive impairment
by: Minoru Kouzuki, et al.
Published: (2022-12-01)

Postirradiation Cognitive and CNS Disabilities
by: J Gordon Millichap
Published: (1994-06-01)

Using mice to model Alzheimer’s dementia: an overview of the clinical disease and the preclinical behavioral changes in ten mouse models
by: Scott J Webster, et al.
Published: (2014-04-01)

Educational bias in the assessment of severe dementia: Brazilian cutoffs for severe Mini-Mental State Examination
by: José Roberto Wajman, et al.
Published: (2014-04-01)

Neuropsychological performance differences between two groups of probable-AD patients from different areas of Brazil
by: Analucy Aury Vieira de Oliveira, et al.

Face Name Associative Memory Exam and biomarker status in the ARMADA study: Advancing reliable measurement in Alzheimer's disease and cognitive aging
by: Dorene M. Rentz, et al.
Published: (2023-07-01)

Teleneuropsychology for vascular cognitive impairment: Which tools do we have?
by: Emilia Salvadori, et al.
Published: (2023-01-01)

Combining cognitive screening tests for the evaluation of mild cognitive impairment in the elderly
by: Rodolfo B. Ladeira, et al.
Published: (2009-01-01)

Discordant Amyloid Status Diagnosis in Alzheimer’s Disease
by: Lorena García-Vallés, et al.
Published: (2022-11-01)

Intraindividual variability across cognitive tasks as a potential marker for prodromal Alzheimer’s disease
by: Andrea Maria Kälin, et al.
Published: (2014-07-01)